Handa Pharmaceuticals, Inc. (TPEX:6620)
86.50
-0.20 (-0.23%)
Jan 22, 2026, 10:39 AM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 13.61 billion as of January 21, 2026. Its market cap has increased by 29.20% in one year.
Market Cap
13.61B
Enterprise Value
11.04B
Revenue
1.62B
Ranking
n/a
PE Ratio
19.09
Stock Price
86.50
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 13.61B, an increase of 63.59%. That is a compound annual growth rate of 5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 13.61B | 0.58% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |